Aura Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:AURA

Comments

Aura Biosciences Inc Earnings Estimates

AURANASDAQ

Trade with Public

$6.54

-0.16-2.39%

At close: Apr 2, 5:00 PM EST

$6.54

N/A

After Hours: Apr 2, 4:00 PM EST

Earnings: Q4 2025 Earnings were released on Mon Mar 30th, before the market open

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Aura Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:AURA

Aura Biosciences (AURA) is scheduled to report Q1 earnings on May 14, 2026. Analysts estimate EPS of $-0.40 and quarterly revenue of N/A.

In the most recent quarter (Q4), Aura Biosciences reported EPS of $-0.37, beating estimates of $-0.43 by 0.14%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Aura Biosciences has beaten EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, Aura Biosciences has averaged an EPS surprise of 0.13% and a revenue surprise of 0.00%.

Earnings Date

May 14

EPS Estimate

$-0.400

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–

Aura Biosciences Earnings History

Analyze the earnings history of Aura Biosciences using advanced sorting and filters.

Loading calendar...

Aura Biosciences (AURA) Earnings Per Share

The chart below shows Aura Biosciences's reported EPS compared to analyst estimates over recent quarters.

Aura Biosciences (AURA) Revenue

The chart below shows Aura Biosciences's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Aura Biosciences (NASDAQ:AURA) reporting earnings?

Aura Biosciences (AURA) is scheduled to report earnings on May 14, 2026. The last reported earnings were for reported on March 30, 2026 for Q4.

What were the latest earnings per share (EPS) for Aura Biosciences (NASDAQ:AURA)?

The Actual EPS was $-0.37, which beat the estimate of $-0.43.

What were Aura Biosciences’s (NASDAQ:AURA) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Larimar Therapeutics Inc

Armata Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc

NASDAQ:EPRX

$7.17

Lexeo Therapeutics Inc

NASDAQ:LXEO

$5.72

Century Therapeutics Inc

NASDAQ:IPSC

$2.34

10.07%

Emergent BioSolutions Inc

NYSE:EBS

$8.23

Aura Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:AURA

Aura Biosciences (AURA) is scheduled to report Q1 earnings on May 14, 2026. Analysts estimate EPS of $-0.40 and quarterly revenue of N/A.

In the most recent quarter (Q4), Aura Biosciences reported EPS of $-0.37, beating estimates of $-0.43 by 0.14%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Aura Biosciences has beaten EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, Aura Biosciences has averaged an EPS surprise of 0.13% and a revenue surprise of 0.00%.

Earnings Date

May 14

EPS Estimate

$-0.400

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–